Urinalysis Market to reach approximately $1.88 bn by end of 2021

Urinalysis Market to reach approximately $1.88 bn by end of 2021

According to the report, global urinalysis market was valued at around USD 1.35 billion in 2015 and is expected to generate revenue of around USD 1.88 billion by end of 2021, growing at a CAGR of around 6.2% between 2016 and 2021.

The urinalysis includes certain screening tests that can help in detection of some of the common diseases. It may be used to screen for and/or help diagnose conditions such as urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. A urinalysis includes a number of microscopic, chemical and visual examinations used to detect cells, cell fragments and various other substances such as casts or crystals in the urine associated with the various conditions listed above. Urinalysis helps in detection of abnormalities which might require additional testing and follow-up investigation. It is often seen that substances such as either glucose or protein will appear in the urine before the patient becomes aware of his illness. Thus, urinalysis plays an important role in monitoring health conditions. The urinalysis is usually carried out as pregnancy check-up, routine medical check-up, pre-surgery preparation, or on hospital admission to treat various disorders.

Request Free Sample Research Report @ http://atozresearch.com/urinalysis-market-consumables-instruments-kidney-diseases-hypertension-urinary-tract-infection-diabetes-liver-diseasesand-forecast-2015-2021/

Growing incidences of target disease such as kidney disorders, liver problems, and diabetes are expected to be the major driver for the global urinalysis market. In addition, growing geriatric population coupled along with the introduction of technologically advanced diagnostics is expected to trigger the growth of urinalysis industry in the coming years. The geriatric population requires regular urinalysis for detection of an array of age-related diseases. However, strict government regulations implied on this industry and lack of healthcare infrastructure may pose the challenge to urinalysis market. Nevertheless, the huge base of the target population and unmet clinical needs in under developed countries is expected to act an opportunity for urinalysis market in near future.

Based on product, urinalysis market has been segmented into consumables, instruments. Urinalysis market was dominated by consumables segment which accounted for largest revenue share across the globe. Reagents, dipstick, and disposables are the major consumables used in urinalysis. Whereas, technological advancements in the instruments segment are estimated to drive the growth of this segment over the forecast period.

The urinalysis market is segmented into the application such as kidney diseases, hypertension, urinary tract infection, diabetes, liver diseases and other applications. In terms of demand, the urinary tract infections (UTI) application segment dominated the market in 2015. Urinary tract infections (UTI) application segment hold more than 20% share of urinalysis market. Kidney diseases, hypertension, and diabetes are other major application segments of urinalysis market. While, diabetes is expected to be the fastest growing application segments of urinalysis market.

North America is expected to remain the dominant region over the forecast period. The strongly established pharmaceutical industry in this region offers good growth opportunities for urinalysis in this region. Moreover, the increasing prevalence of chronic diseases coupled along with increasing patient awareness levels is also boosting the market in this region. Europe was a second largest market for urinalysis in 2015. Asia-Pacific is projected to be the fastest-growing region for urinalysis market during the forecast period. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.

Some of the key players in urinalysis market are Mindray, Roche Diagnostics, Siemens Healthcare, Sysmex, ARKRAY Inc., Alere Inc., ACON Laboratories, Inc., Bio-Rad, Labomed, Inc.Teco Diagnostics and Urit Medical., among others.